Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent progress in cerebrovascular gene therapy.

Naoyuki Sato1, Munehisa Shimamura, Ryuichi Morishita

  • 1Division of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, Suita, Japan.

Current Neurovascular Research
|September 27, 2005
PubMed
Summary

Gene therapy shows promise for treating cardiovascular diseases and neurological conditions like stroke. Further research into safe and effective gene delivery systems is crucial for advancing cerebrovascular gene therapy in humans.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fibroblast activation protein protects the ischemic brain through regulation of post-ischemic inflammation.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2026
Same author

CCN1/Cyr61 associates with β-amyloid levels in human cerebrospinal fluids.

iScience·2026
Same author

A RANKL-derived Peptide Inhibits RSPO3-LGR4-Wnt Signaling and Lung Adenocarcinoma in Mice.

Anticancer research·2026
Same author

Needle-Free Injection Enhances the Immunogenicity and Antitumor Efficacy of Whole-Cell Tumor Vaccines.

Vaccines·2026
Same author

Coordinated regional association of cathepsins and dipeptidyl peptidases with N-truncated Abeta42, Abeta40, and tau in Alzheimer's brain.

Acta neuropathologica communications·2025
Same author

γ-Secretase exosites as targets for substrate-selective lowering of Aβ generation.

Structure (London, England : 1993)·2025

Area of Science:

  • Biomedical Engineering
  • Molecular Medicine
  • Regenerative Medicine

Background:

  • Gene therapy is a promising treatment for cardiovascular diseases, with over 20 clinical trials underway.
  • Cerebrovascular gene therapy, while not yet in clinical trials, has shown potential in experimental models.

Purpose of the Study:

  • To explore the potential of gene therapy for cerebrovascular diseases, including vasospasm, ischemic stroke, and post-angioplasty restenosis.
  • To review current experimental strategies and identify challenges in translating cerebrovascular gene therapy to human clinical applications.

Main Methods:

  • Review of experimental models for cerebrovascular gene therapy.
  • Analysis of gene therapy strategies targeting vasospasm, neuroprotection, and angiogenesis.

Related Experiment Videos

  • Identification of key challenges including transfection efficiency and vector safety.

    • Main Results:

    • Experimental gene therapy using vasodilating proteins or decoy oligodeoxynucleotides showed efficacy against vasospasm post-subarachnoid hemorrhage (SAH).
    • Growth factors like Brain-derived neurotrophic factor (BDNF), Fibroblast growth factor-2 (FGF-2), and Hepatocyte growth factor (HGF) demonstrated neuroprotective and angiogenic effects in ischemic stroke models.

    Conclusions:

    • Gene therapy holds significant potential for treating cerebrovascular conditions where current therapies are inadequate.
    • Development of safe and efficient gene delivery systems is essential for the clinical application of human cerebrovascular gene therapy.